project id: TCGA-BRCA; case submitter id: TCGA-B6-A0I1; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.95; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.9; rna integrity number: 8.7; age at index: 73; days to birth: -26902; days to death: 2361; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Dead; year of birth: 1925; year of death: 2004; age at diagnosis: 26902; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T2; ajcc staging system edition: 5th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8500/3; primary diagnosis: Infiltrating duct carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 1998; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 4248; days to sample procurement: 0; initial weight: 100.0; portion submitter id: TCGA-B6-A0I1-01A-11; percent monocyte infiltration: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent tumor nuclei: 65.0;